SeaStar Medical Holding Corp (ICUCW) income statement

ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value

$0.01−0.01 (-34.73%)

Close on Oct 30, 2026Market cap $9.87MP/E –Yield –

SeaStar Medical Holding Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	1.23	0.14	0	–	–
Cost of Revenue	0.05	0	0	–	–
Gross Profit	1.18	0.14	0	–	–
Research & Development	7.52	9.11	5.97	2.50	2.77
General & Administrative	5.84	8.87	8.24	6.92	1.68
Operating Expenses	13	18	14	12	4.45
Operating Income	-12	-18	-14	-12	-4.45
Interest Expense	0.03	0.24	1.08	0.63	0.21
Interest & Investment Income	0.33	0.10	0	–	0.01
Other Non-Operating Income	0.03	-6.99	-12	-0.58	-0.15
Pretax Income	-12	-25	-26	-12	-4.60
Income Tax Expense	0.00	0.00	0	0.00	0.00
Net Income incl. Noncontrolling Interests	–	-25	-26	-12	-4.60
Net Income	-12	-25	-26	-12	-4.60
EPS (Basic)(per share)	-5.86	-66.33	-302.60	-370.00	-157.50
EPS (Diluted)(per share)	–	-66.30	-302.60	-370.00	-157.50
Shares Outstanding (Basic, Weighted)(shares)	2.07	0.37	0.09	0.03	0.03
Shares Outstanding (Diluted, Weighted)(shares)	2.07	0.37	0.09	0.03	0.03

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 92.6%
Operating margin: -816.6%
Net margin: -795.5%
Return on equity, FY2025: -295.2%

Financial strength

Current ratio: 1.89
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 159.9%

Valuation

P/E ratio: –
Price to sales: 5.76
Price to book: 2.30
Dividend yield: –